News | December 15, 2025
Eiko LifeSciences to acquire 51% stake in SSM Formulations
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
WINREVAIR is currently the first and only activin signalling inhibitor approved for PAH across all 27 EU member states
The approval of Augmentin XR, granted to USAntibiotics, directly supports the CNPV program’s goals
The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
The new centre brings advanced corneal procedures pioneered in India
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
The new site marks the company’s first operation in the region
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
Subscribe To Our Newsletter & Stay Updated
